Insider · CIK 0002083937
Thomas Fuchs
director
Files at WGS (GeneDx Holdings Corp.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +1,146 | $0.00 | $0 | 1,146 | 24 d ago |
| Sep 17, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -1,146 | $0.00 | $0 | 2,292 | 24 d ago |
| Sep 17, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | -3,438 | $0.00 | $0 | 3,438 | Sep 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.